Major Change for TRICARE Coverage of Breakthrough Alzheimer's Drug
November 26, 2025
November 26, 2025
WASHINGTON, Nov. 26 -- The Military Officers Association of America issued the following news:
* * *
Major Change for TRICARE Coverage of Breakthrough Alzheimer's Drug
A first-of-its-kind drug treating early stage Alzheimer's disease via in-home injection has been added to the TRICARE formulary.
Patients who receive the monoclonal antibody Leqembi via intravenous infusion every two weeks for 18 months now may continue treatment with s . . .
* * *
Major Change for TRICARE Coverage of Breakthrough Alzheimer's Drug
A first-of-its-kind drug treating early stage Alzheimer's disease via in-home injection has been added to the TRICARE formulary.
Patients who receive the monoclonal antibody Leqembi via intravenous infusion every two weeks for 18 months now may continue treatment with s . . .